Medrio’s ePRO Accreditation eLearning Takes Silver in Davey Awards

San Francisco, CA (November 7, 2022)—Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, is pleased to announce it received a Silver Award at the 2022 Davey Awards for its “Build It Better: ePRO Accreditation Program.” Medrio was recognized out of more than 2,000 entrants with a Silver Award in the General, Training for Websites category. 

In its 18th year, the Davey Awards are an annual international award program recognizing excellence in creative design and advertising categories and highlighting creative work by small agencies and companies managed by the Academy of Interactive and Visual Arts (AIVA)

“We are thrilled to receive this industry recognition of our ePRO eLearning program,” said Fred Martin, Medrio’s Chief Operating Officer. “Medrio is committed to delivering eClinical technologies that are intuitive and purpose-built for ease-of-use from day one by our customers, but it doesn’t stop there. We offer a continuum of support and flexible training in face-to-face, virtual, and on-demand formats to meet our customers where they are and support their long-term success.” 

About Medrio

Medrio is on a mission to ease complexity in today’s hybrid, decentralized, and site-based clinical trials by delivering a flexible suite of eClinical technologies and services, including EDC, eCOA, ePRO, eConsent, Direct Data Capture, and Randomization and Trial Supply Management (RTSM). Trusted by contract research organizations (CROs), sponsors, and sites across all therapeutic areas and trial phases from study startup and feasibility to post-market approval since 2005, Medrio is industry-recognized for delivering eClinical software with intuitive interfaces and time-saving “drag and drop” configurations as well as high-touch customer engagement, onboarding, and support services. Learn how they do it at


Denise Spillane

Enter a topic, term or keyword below:

Subscribe to our mailing list

Sign up to have our the latest insights delivered to your inbox.